Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

The finding is significant because people can use CGM data to make dietary and lifestyle changes, which may be unnecessary, and the erroneously high readings (indicating glycaemia) could lead them to ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...

Medtronic ( MDT -0.99%) and Abbott Laboratories ( ABT -1.91%) are two such examples in the healthcare industry. Both are ...

Abbott announced that it made its Lingo continuous glucose monitoring (CGM) system available for purchase on Amazon.

Abbott had claimed that the shape of Sinocare’s iCan i3 wearable CGM was too similar to its own FreeStyle Libre sensor—in this case, the small, white disc placed on the upper arm. Sinocare ...

DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% ...

They let you keep track of your blood sugar levels in a less invasive way. One type of CGM is Abbott’s Freestyle Libre. Medicare took some time to accept these devices. However, for the last few ...

Abbott's ABT diversified business portfolio is well-positioned to drive momentum. However, the international business ...